Search

everythinglearnresearchcommunity

for

Search:↓

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

High-frequency ultrasound effectively measures basal cell carcinoma depth.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

PCOS is the main cause of hirsutism, often linked to insulin resistance.

Keratin 75 might be important in oral cancer progression.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Medication can effectively reduce hair growth and improve life quality for women with hirsutism.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

17b-Estradiol in skin affects hair growth and tumor promotion.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.